
Virtual Summit on Mental Health Integration in Pediatric Rheumatology
Free
- Length
- 2 hr 30 min
- Platform
- Zoom
- Topic
- Medical & Clinical
About this webinar
The Interferon Connection: Understanding Mood and Mind in Juvenile Myositis
Mental health is part of the whole picture in juvenile myositis, and Cure JM is bringing together leading experts to explore why.
We know that individuals with autoimmune disease are more likely than the general population to experience symptoms of anxiety and depression. Stress, chronic pain, and disease burden all play a role, but there's more to the story. Emerging science shows that interferon, a key driver of autoimmune inflammation, can act directly on the brain, meaning mood symptoms in JM aren't just a response to living with a hard diagnosis; they can also be biologically driven by the disease itself.
Join Dr. GenaLynne Mooneyham, a physician-researcher at the National Institutes of Health (NIH) and Medical Director of the National Institute of Mental Health Autoimmune Brain Disorders Program, for an in-depth examination of this mind-body connection and why mental health symptoms warrant the same clinical attention as physical symptoms. Dr. Mooneyham will also address how treating the whole person, through a biopsychosocial model and close collaboration across specialties, leads to improved outcomes for patients and families.
A panel discussion will follow, featuring leaders in the field alongside patients and caregivers sharing their perspectives on what it's like to manage JM and mental health together. Real stories, real resilience, real hope.
This free event is open to the entire Cure JM community: Medical providers and the patients, parents, and caregivers they serve. Whether you're looking for answers, validation, or connection, this summit is for you.



